€
3. 06
+0.06
+2%
€
1.09B Market Cap
- P/E Ratio
- Div Yield
300 Volume
- Eps
€ 3
Previous Close Want to track 6HN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Everest Medicines Ltd. (6HN) Statistics
Valuation metrics
Market Cap 1.09B
Enterprise value -93.93M
Trailing P/E (ttm) -3.39
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.62
Price/Book (mrq) 1.57
Enterprise Value/Revenue -0.43
Enterprise Value/EBITDA 3.49
Overview
Shares outstanding 351.34M
Float 305.46M
Shares short -
% Held by insiders 0.06%
% Held by institutions 0.4%
Average volume (10 days) 56
Average volume (90 days) 75
Price summary
52-Week low 2.48
52-Week high 7.9
Beta 1.5
50-Day moving average 3.74
200-Day moving average 4.63
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2020
Profitability
Profit margin -0.17%
Operating margin -0.05%
Operational effectiveness
Return on assets -0.04%
Return on equity -0.06%
Income Statement
Revenue (ttm) 217.48M
Revenue per share (ttm) 5.07
Quarterly revenue growth (yoy) 2.11%
Gross profit (ttm) 150.6M
EBITDA -26.91M
Net income to common (ttm) -37.94M
Diluted EPS (ttm) -0.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 348.07M
Total cash per share (mrq) 7.77
Total debt (mrq) 118.04M
Total Debt/Equity (mrq) 17.46
Current ratio (mrq) 4.89%
Book value per share (mrq) 1.92
Cash Flow
Cash flow statement -11.79M
Levered free cash flow (LFCF) -29.1M
